register

News & Trends - MedTech & Diagnostics

Australia takes global lead with latest robotic-assisted knee replacement technology

Health Industry Hub | March 13, 2024 |

MedTech & Diagnostics News: In a milestone for orthopaedic surgery, the Australian Institute of Robotic Orthopaedics (AIRO) has been granted the Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its high-speed Intelligent Laser Osteotomy (HAiLO™) system in knee replacement procedures.

The HAiLO system represents a pioneering fusion of non-contact laser energy, surgical robotics, and real-time intraoperative digital sensing. This integration empowers orthopaedic surgeons with unprecedented precision, enabling them to achieve sub-millimetre accuracy in both full and partial knee replacement surgeries.

AIRO’s co-founder and CEO, Associate Professor Brett Robertson, underscored the system’s capacity to tailor surgical solutions to the unique needs of individual patients.

“Receiving the Breakthrough Device Designation from the FDA validates the innovative nature of our technology, its commercial potential, and, most importantly, its significant potential benefits to patients worldwide,” Professor Robertson remarked.

Professor Riaz Khan, Orthopaedic Surgeon and AIRO Chairman, echoed Associate Professor Robertson’s sentiments, emphasising the impact of the HAiLO system on orthopaedic surgery.

“The HAiLO system will change the practice of orthopaedics as we know it today,” Professor Khan declared. He elaborated on the system’s transformative capabilities, particularly its real-time digital mapping and non-contact laser bone shaping features, envisioning a future where knee replacement surgery results in near-normal joint function, akin to a ‘forgotten knee.’

With over 1.4 million knee replacement surgeries performed globally each year, the HAiLO system aims to address the dissatisfaction often experienced by patients with traditional methods. By mitigating misalignment, thermal and mechanical bone damage, and preserving crucial ligaments, AIRO’s innovative approach sets a new standard in orthopaedic care.

“Our vision at AIRO is to restore vitality and movement to the world,” Professor Robertson reiterated, highlighting the company’s commitment to enhancing the lives of millions through next-generation implants. “In doing so,” he concluded, “we aim to raise global standards in orthopaedic care.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.